Isoflavones, lignans and stilbenes - Origins, metabolism and potential importance to human health

Journal of the Science of Food and Agriculture

Volumn 80, Issue 7, 2000, Pages 1044-1062

  Cassidy, Aedin ^a   Hanley, Bryan ^b,d   Lamuela Raventos, Rosa M ^c  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b CSL Food Science Laboratory   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRAL SCIENCE LABORATORY   (United Kingdom)

Author keywords

Daidzein; Diarylbutanes; Diarylethylenes; Enterodiol; Enterolacton e; Genistein; Grapes; Isoflavones; Legumes; Lignans; Miso; Oestr ogen receptor; Phytoestrogens; Resveratrol; Seco isolariciresinol; Soya; Stilbenes; Tempeh; Tofu; Wines

Indexed keywords

DIET; HORMONE ACTION; HUMAN HEALTH; ISOFLAVONE; LIGNAN; METABOLISM; PHYTOESTROGEN; STILBENE;

EID: 0034658373     PISSN: 00225142     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0010(20000515)80:7<1044::AID-JSFA586>3.0.CO;2-N     Document Type: Review

References (158)

1. Setchell KDR and Adlercreutz HA, Mammalian lignans and phytoestrogens. Recent studies on their formation, metabolism and biological role in health and disease, in Role of the Gut Flora in Toxicity and Cancer, Ed by Rowland IR. Academic Press, New York, pp 315-345 (1988).
2. Miksicek RJ, Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med 208:44-50 (1995).
3. Metzger D, Berry M, Ali S and Chamber P, Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol 9:579-591 (1995).
4. Markiewicz L, Garey J, Adlercreutz H and Gurpide E, In vitro bioassays of non steroidal phytoestrogens. J Steroid Biochem Mol Biol 45:399-405 (1993).
5. Montano MM, Muller V, Trobaugh A and Katzenellenbogen BS, The carboxy terminal F domain of the human estrogen receptor: role on the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol Endocrinol 9:814-825 (1995).
6. Petit F, Valotaire Y and Pakdel F, Differential functional activities of rainbow trout and human estrogen receptors expressed in the yeast. Saccharomyces cerevisiae. Eur J Biochem 233:548-592 (1995).
7. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA, Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930 (1996).
8. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S and Gustafsson JA, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870 (1997).
9. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ and Scanlan TS, Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508-1510 (1997).
10. Ebel J, Phytoalexin synthesis: the biochemical analysis of the induction process. Ann Rev Phytopathol 24:235-264 (1986).
11. Rolfe BG, Flavenes and isoflavones as inducing substances of legume modulation. Biofactors 1:3-10 (1988).
12. Ayres DC and Loike JD, Lignans: chemical, biological and clinical properties, in Chemistry and Pharmacology of Natural Products. Cambridge University Press, Cambridge, 420 pp (1990).
13. Dinkova-Kostova AT, Gang DR, Davin LB, Bedgar DL, Chu A and Lewis NG, (+)-Pinoresinol-(+)-lariciresinol reductase from Forsythia intermedia: protein purification, cDNA cloning, heterolegous expression and comparison to isoflavone reductase. J Biol Chem 271:29473-29482 (1996).
14. Thompson LU, Robb P, Serraino M and Cheung F, Mammalian lignan production from various foods. Nutr Cancer 16:43-52 (1991).
15. Reinli K and Block G, Phytoestrogen content of foods - a compendium of literature values. Nutr Cancer 26:123-148 (1996).
16. Hanson CH, Loper GM and Kohler GO, Variation in coumestrol content of alfalfa, as related to location, variety, cutting, year, stage of growth, and disease. US Dept of Agriculture, Agricultural Research Service Technical Bulletin 1333 (1965).
17. Morley FH and Francis CM, Varietal and environmental variations in isoflavone concentrations in subterranean clover. Aust J Agric Sci 19:15-26 (1968).
18. Coward L, Barnes NC, Setchell KDR and Barnes S, Genistein and daidzein and their β-glycoside conjugates: anti-tumour isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 41:1961-1967 (1993).
19. Eldridge AC, Determination of isoflavones in soybean flours, protein concentrates and isolates. J Agric Food Chem 30:353-355 (1982).
20. Setchell KDR, Welsh M and Lim CK, High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection. J. Chromatogr 386:315-323 (1987).
21. Barnes S, Kirk M and Coward L, Isoflavones and their conjugation soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem 42:2466-2474 (1994).
22. Kudou S, Fleury Y, Welti D, Magrolato D, Uchida T, Kitamura K and Okubu K, Malonyl isoflavone glycosides in soyabean seeds. Agric Biol Chem 55:2227-2234 (1991).
23. Setchell KDR, Borriello SP, Hulme P, Kirk DN and Axelson M, Non-steroidal oestrogens of dietary origin: possible roles in hormone dependent disease. Am J Clin Nutr 40:569-578 (1984).
24. Dwyer JT, Goldin BR, Saul N, Gaulkitieri L, Barakat S and Adlercreutz H, Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 94:739-743 (1994).
25. Haworth RD and Slinger FH, The constituents of natural phenolic resins. Part XVII. A synthesis of 1-matairesinol. J Chem Soc 1098-1101 (1940).
26. Rao CBS, The Chemistry of Lignans. Andhra University Press, Waltair (1978).
27. Nesbitt D, Lam Y and Thompson LU, Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69:549-555 (1999).
28. Luckner M (Ed), Secondary Metabolism in Microorganisms, Plants, and Animals, 3rd edn. Springer, Jena, p 405 (1990).
29. Gorham J, Stilbenes and Phenanthrenes, vol 1 of Methods in Plant Biochemistry. Academic Press, New York, 1989, pp 159-189.
30. Chung MI, Teng CM, Cheng KL, Ko FN and Un CN, An antiplatelet principle of Veratrum formosanum. Planta Med 58:274-275 (1992).
31. Langcake P, Disease resistance of Vitis spp. and the production of the stress metabolites resveratrol, δ-viniferin, β-viniferin and pterostilbene. Physiol Plant Pathol 18:213-226 (1981).
32. Barlass M, Miller RM and Douglas TJ, Development of methods for screening grapevines for resistance to infection by downy mildew. II. Resveratrol production. Am J Enol Vitic 38:65-68 (1987).
33. Dercks W and Creasy LL, The significance of stilbene phytoalexins in the Plasmopara viticola-grapevine interaction. Physiol Mol Plant Pathol 34:189-202 (1989).
34. Jeandet P, Sbaghi M and Bessis R, The production of resveratrol (3,4,5′-trihydroxystilbene) by grapevine in vitro cultures, and its application to screening for grey mould resistance. J Wine Res 3:47-57 (1992).
35. Langcake P and Pryce RJ, The production of resveratrol and the viniferins by grapevines in response to ultraviolet irradiation. Phytochemistry 16:1193-1196 (1977).
36. Korhammer S, Reniero F and Mattivi F, An oligostilbene from Vitis roots. Phytochemistry 38:1501-1504 (1995).
37. Creasy LL and Coffee M, Phytoalexin production potential of grape berries. J Am Soc Hort Sci 113:230-234 (1988).
38. Jeandet P, Bessis R and Gautheron B, The production of resveratrol (3,5,4″)-trihydroxystilbene by grape berries in different development stages. Am J Enol Vitic 42:41-46 (1991).
39. Langcake P and Pryce RJ, The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 9:77-86 (1976).
40. Sbaghi M, Jeandet P, Bessis R and Leroux P, Degradation of stilbene-type phytoalexins in relation to the pathogenicity of Borrytis cinerea to grapevines. Plant Pathol 45:139-144 (1996).
41. Macheix J-J, Fleuriet A and Billot J, Fruit Phenolics. CRC Press, Boca Raton, FL (1990).
42. Blaich R and Bachmann O, Die Resveratrolsynthese bei Vitaceen: Induktion und zytologische Beobachtungen. Vitis 19:230-240 (1980).
43. Blaich R, Bachmann O and Stein U, Causes biochimiques de la resistence de la vigne a Botrytis cinerea. EPPO Bull 12:167-170 (1982).
44. Pool RM, Creasy LL and Frackelton AS, Resveratrol and the viniferins, their application to screening for diseases resistance in grape breeding programs. Vitis 20:136-145 (1981).
45. Waterhouse AL and Lamuela-Raventós RM, The occurrence of piceid, a stilbene glucoside, (polydatin) in grape berries. Phytochemistry 37:571-573 (1994).
46. Lamuela-Raventós RM, Romero-Pérez AI, Waterhouse AL and de la Torre-Boronat MC, Direct HPLC analysis of cis- and trans-resveratrol and piceid isomers in Spanish red Vitis vinifera wines. J Agric Food Chem 43:281-283 (1995).
47. Mattivi F, Reniero F and Korhammer S, Isolation, characterization, and evolution in red wine vinification of resveratrol monomers. J Agric Food Chem 43:1820-1823 (1995).
48. Jeandet P, Bessis R, Maume BF, Meunier P, Peyron D and Trollat P, Effect of enological practices on the resveratrol isomer content of wine. J Agric Food Chem 43:316-319 (1995).
49. Okuda T and Yokotsuka K, trans-Resveratrol concentrations in berry skins and wines from grapes grown in Japan. Am J Enol Vitic 47:93-99 (1996).
50. Bavaresco L, Action du potassium sur la synthese induite du stilbene chez differents varietes de vigne. Bull OIV, pp 676-689 (1993).
51. Romero-Pérez AI, Lamuela-Raventós RM, Waterhouse AL and de la Torre-Boronat MC, Levels of cis- and trans-resveratrol and piceid isomers in rose and white Vitis vinifera wines. J Agric Food Chem 44:2124-2128 (1996).
52. Ector BJ, Magee JB, Hegwood CP and Coign MJ, Resveratrol concentration in Muscadine berries, juice, pomace, purees, seeds, and wines. Am J Enol Vitic 47:57-62 (1996).
53. Pezet R and Cuenat P, Resveratrol in wine: extraction from skins during fermentation and post-fermentation standing of must from Gamay grapes. Am J Enol Vitic 47:287-290 (1996).
54. Lamuela-Raventós RM, Romero-Pérez AI, Waterhouse AL, Lloret M and de la Torre-Boronat MC, Resveratrol and piceid levels in wine production and in finished wines, in Wine: nutritional and Therapeutical Benefits, Ed by Watkins TR. American Chemical Society, Washington, DC, pp 56-68 (1997).
55. Vrhovsek U, Wendelin S and Eder R, Effects of various vinification techniques on the concentration of cis- and trans-resveratrol and resveratrol glucosides isomers in wine. Am J Enol Vitic 48:214-219 (1997).
56. Romero-Pérez AI, Lamuela-Raventos RM, Buxaderas S and de la Torre-Boronat MC, Resveratrol and piceid as varietal markers of white wines. J Agric Food Chem 44:1975-1978 (1996).
57. Wightman JD, Price SF, Watson BT and Wrolstad RE, Some effects of processing enzymes on anthocyanins and phenolics in Pinot Noir and Cabernet Sauvignon wines. Am J Enol Vitic 48:39-48 (1997).
58. Romero-Pérez AI, Ibern-Gómez M, Lamuela-Raventós RM and de la Torre-Boronat MC, Piceid, the major resveratrol derivative in grape juices. J Agric Food Chem 47:1533-1536 (1999).
59. Axelson M and Setchell KDR, Conjugation of lignans in human urine. FEBS Lett 122:49-53 (1980).
60. Axelson M and Setchell KDR, The excretion of lignans in rats - evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 123:337-342 (1981).
61. Axelson M, Sjovall J, Gustafsson BE and Setchell KDR, Origin of lignans in mammals and identification of a precursor from plants. Nature 298:659-660 (1982).
62. Setchell KDR, Lawson AM, Borriello SP, Harkness R, Gordon H, Morgan DML, Kirk DN, Adlercreutz H and Axelson M, Lignan formation in man - microbial involvement and possible roles in relation to cancer. Lancet 2:4-8 (1981).
63. Venkataraman PS, Neylon MJ, Carlson J and Setchell KDR, Urinary phytoestrogen excretion in infants: differences between human milk, cow-based milk and soy formula fed infants. Pediatr Res 33:312A (1993).
64. Setchell KDR, Zimmer-Nechemias , Cai J and Haub JE, Exposure of infants to phytoestrogens from soy-based infant formulas. Lancet 350:23-27 (1997).
65. Yasuda T, Mizunuma S, Kano Y, Saito K and Oshawa K, Urinary and biliary metabolites of genistein in rats. Biol Pharmaceut Bull 19:413-417 (1996).
66. Sfakianos J, Coward L, Kirk M and Barnes S, Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 127:1260-1268 (1997).
67. Clerici C, Gentili G, Distrutti E, Modesta R, Morelli A and Setchell K, The effect of isoflavones, ethynylestradiol and tamoxifen on bile flow and biliary lipid secretion. Hepatology 18:296A (1993).
68. Kelly GE, Nelson C, Waring MA, Joannou GE and Reeder AY, Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 223:9-22 (1993).
69. Mackenzie PI, Redbourne L and Stranks S, Steroid UDP glucuronosyl transfer uses. J Steroid Biochem Mol Biol 43:1099-1105 (1992).
70. Martucci CP and Fishman J, P450 enzymes of estrogen metabolism. Pharmacol Therapeut 57:237-257 (1993).
71. Setchell KDR, Discovery and potential clinical importance of mammalian ligans, in Flaxseed in Human Nutrition, pp 82-98. Ed by Cunanne SC and Thomson LU. AOCS Press, Champaign, IL (1995).
72. Zimmer-Nechemias L, Setchell KDR and Balistreri WF, Glucuronidation of bile acids and lignan by immature rat liver. Clin Res 33:878A (1985).
73. Morton MS, Wilcox G, Wahlqvist ML and Griffiths K, Determination of lignans and isoflavones in human female plasma following dietary supplementation. J Endocrinol 142:251-259 (1994).
74. Adlercreutz H, Fotsis T, Lampe J, Wahala K, Makela T, Brunow G and Hase T, Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass speć trometry. Scand J Clin Lab Invest (Suppl 215) 53:5-18 (1993).
75. Nilsson A, Hill IL and Davies HL, An in vitro study of formononetin and biochanin A metabolism in rumen fluid from sheep. Biochim Biophys Acta 148:92-98 (1967).
76. 14C biochanin-A in sheep. Aust J Agric Res 22:131-138 (1971).
77. Bannwart C, Adlercreutz HA, Fotsis T, Wahala K, Hase T and Brunow G, Identification of O-desmethylangolensin, a metabolite of daidzein and of matairesinol, one likely plant precursor of the animal lignan enterolactone, in human urine. Finn Chem Lett 4-5:120-125 (1984).
78. Bannwart C, Adelrcreutz HA, Wahala K, Brunow G and Hase T, Isoflavonic phytoestrogens in humans. Identification and metabolism. Eur J Cancer Clin Oncol 23:1732 (1987).
79. Adlercreutz HA, Hockerstedt K and Bannwart C, Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). Steroid Biochem 27:1135-1144 (1987).
80. Joannou GE, Kelly GE, Reeder AY, Waring M and Nelson C, A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 54:167-184 (1995).
81. Cassidy A, Bingham S and Setchell KDR, Biological effects of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60:333-340 (1994).
82. Cassidy A, Plant oestrogens and their relation to hormonal status in women. PhD Thesis, Cambridge University (1991).
83. Cassidy A, Bingham S and Setchell KDR, Biological effects of isoflavones in young women - importance of the chemical composition of soya products. Br J Nutr 74:587-601 (1995).
84. Xu X, Wang H-J, Murphy PA, Cook L and Hendrich S, Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124:825-832 (1994).
85. Shino M, Pharmacokinetic study of ipriflavone by oral administration in healthy male volunteers. Jpn J Pharmacol Ther 13:235-245 (1985).
86. Yoshida K, Tsukamoto T, Torii H, Doi T, Naeshiro I, Shibata K, Uemura I and Tanayama S, Disposition of ipriflavone (TC-80) in rats and dogs. Radioisotopes 34:618-623 (1985).
87. King RA, Broadbent JL and Head R, Absorption and excretion of the soy isoflavone genistein in rats. J Nutr 126:176-182 (1996).
88. Yueh T-L and Chu H-Y, The metabolic fate of daidzein. Sci Sinica 20:513-521 (1997).
89. Rondelli I, Acerbi D and Ventura P, Steady state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure. Int J Clin Pharmacol Res 11:183-192 (1991).
90. Setchell KDR and Cassidy A, Dietary isoflavones - biological effects and relevance to human health. J Nutr 129:758S-767S (1999).
91. Nagata C, Takatsuka N, Kurisu Y and Shimizu H, Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 128:209-213 (1998).
92. Irvine CHG, Fitzpatrick MG and Alexander SL, Phytoestrogens in soya-based infant foods: concentrations, daily intake and possible biological effects. Proc Soc Exp Biol Med 217:247-253 (1998).
93. Murphy PA, Seng T, Buseman G and Barva K, Isoflavenes on soy-based infant formula. J Agric Food Chem 45:4635-4638 (1997).
94. Cassidy A, Physiological effects of phyto-oestrogens in relation to cancer and other human health risks. Proc Nutr Soc 55:399-417 (1996).
95. Franke AA and Custer LJ, Daidzein and genistein concentrations in human milk after soy consumption. Clin Chem 42:955-964 (1996).
96. Lampe JW, Karr SC, Hutchins AM and Slavin JL, Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217:335-339 (1998).
97. Setchell KDR, Phytoestrogens: the biochemistry, physiology and implications for human health of soy isoflavones. Am J Clin Nutr 68:1333S-1346S (1998).
98. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wahala K and Adlercreutz H, Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60g baked soyabean powder. J Nutr 128:1710-1715 (1998).
99. Gamache PH, Maher TJ, Setchell KDR, Wu T-H and Alworth IN, The transfer of non-steroidal dietary estrogens into the brain. Soc Neurosci Abstr 22:1-3 (1996).
100. Rickard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong HH and Thompson LU, Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 126:2012-2019 (1996).
101. Juan ME, Lamuela-Raventos RM, de la Torre-Boronat MC and Planas JM, Determination of trans-resveratrol in plasma by HPLC. Anal Chem 71:747-750 (1999).
102. Bertelli AAE, Giovannini L, Stradi R, Urien S, Tillement J-P and Bertelli A, Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp Clin Res 24:51-55 (1998).
103. Hollman PCH, Bioavailability of flavonoids. Eur J Clin Nutr 51:S66-S69 (1997).
104. Renaud S and de Lorgeril M, Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523-1526 (1992).
105. Lewis DFV, Parker MG and King RJB, Molecular modeling of the human estrogen receptor and ligand interactions based upon site-directed mutagenesis and amine acid sequence homology. J Steroid Biochem Mol Biol 52:55-65 (1995).
106. Edwards DP, Adams DJ, Savage N and McGuise WL, Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochem Biophys Res Commun 93:804-812 (1980).
107. King WJ and Greene GL, Monoclonal antibodies localize oestrogen receptor on the nuclei of target cells. Nature 307:745-746 (1984).
108. Wrenn CK and Katzenellenbogen BS, Structure-function analysis of the hormone binding zone of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J Biol Chem 268:24089-24098 (1993).
109. Schwabe JWR, Chapman L and Rhocks D, The oestrogen receptor recognises an imperfectly palindromic response element through an alternative side chain conformation. Structure 3:201-213 (1995).
110. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-A and Carlquist M, Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758 (1997).
111. Nichols M, Rientses JMJ and Stewart AF, Different positioning of the ligand binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists. EMBO J 17:765-773 (1998).
112. Lefstin JA and Yamamote KR, Allosteric effects of DNA on transcriptional regulators. Nature 392:885-888 (1998).
113. Grohe C, Kahlert S, Loebbert K and Vetter H, Expression of estrogen receptor alpha and beta in rat heart: role of local estrogen synthesis. J Endocrinol 16:377-384 (1998).
114. Sturdee DW, Clinical symptoms of oestrogen deficiency. Curr Obstet Gynaecol 7:190-196 (1997).
115. Xu X, Wang H-J, Murphy PA, Cook LR and Heuchich S, Disposition of a single dose of soy milk isoflavones in adult females, in Natural Protectants against Natural Toxicants, Ed by Bidlack WR and Omage ST, Technomic Publishing Co, pp 51-58 (1994).
116. Orcheson LJ, Rickard SE, Seidl MM and Thompson LU, Flaxseed and its mammalian lignan precursor cause a lengthening or cessation of estrous cycling in rats. Cancer Lett 125:69-76 (1998).
117. Treolar AE, Boynton RE, Behn BG and Brown BW, Variation of the human menstrual cycle through reproductive life. Int J Fertil 12:77-126 (1970).
118. Henderson BE, Ross RK, Judd HL, Krailo MD and Pike MC, Do regular ovulatory cycles increase breast cancer risk?. Cancer 56:1206-1208 (1985).
119. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M and Coward L, Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol, Biomark Prevent 5:785-794 (1996).
120. Ingram D, Sanders K, Kolybaba M and Lopez D, Case-control study of phyto-oestrogens and breast cancer. Lancet 350:990-994 (1997).
121. Hsieh C-Y, Santell RC, Haslam SZ and Helferich WG, Estrogenic effects of genistein on the growth of estrogen receptor positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58:3833-3838 (1998).
122. Mgbonyebi OP, Russo J and Russo IH, Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 12:865-869 (1998).
123. Sathyamoorthy N, Wang TT and Phang JM, Stimulation of p52 expression by diet-derived compounds. Cancer Res 54:957-961 (1994).
124. Keung WM and Wong C-K, Phytoestrogen sulfoconjugates as inhibitors of sterol sulfatases. Biochem Soc Trans 27:21-22 (1998).
125. World Cancer Research Fund, Food Nutrition and the Prevention of Cancer: a Global Perspective. American Institute for Cancer Research, Washington, DC (1997).
126. Sung M-K, Lautens M and Thomson LU, Mammalian hormones inhibit the growth of estrogen-independent human colon tumor cells. Anti Cancer Res 18:1405-1408 (1998).
127. Serraino MR and Thompson LU, The effect of flaxseed supplementation on the imitation and promotional stages of mammary tumorigenesis. Nutr Cancer 17:153-159 (1992).
128. Van L, Yee JL, Li D, McGuire MM and Thomson LU, Dietary flaxseed supplementation and experimental metastases of melanoma in mice. Cancer Lett 124:181-186 (1998).
129. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC and Pezzuto JM, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220 (1997).
130. Fontecave M, Lepoivre M, Elleingand E, Gerez C and Guiter O, Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421:277-279 (1998).
131. Sun NJ, Woo SH, Cassady JM and Snapka RM, DNA-polymerase and topoisomerase-II inhibitors from. Psoralea corylifolia J Nat Prod 61:362-366 (1998).
132. Della Ragione F, Cucciolla V, Borriello A, Della Prieta V, Racioppi L, Soldati G, Manna C, Galletti P and Zappia V, Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 250:53-58 (1998).
133. Matthews K, Meilahn E, Kuller LH, Kelsey PHSF, Caggiula AW and Wing RR, Menopause and risk factors for coronary heart disease. New Engl J Med 321:641-646 (1989).
134. Key TJA, Thorogood M, Appleby PN and Burr ML, Dietary habits and mortality in 11000 vegetarians and health conscious people: results of a 17 year follow up. Br Med J 313:775-779 (1996).
135. Anthony MS, Clarkson TB, Hughes Jr CL, Morgan TM and Burke GL, Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126:43-50 (1996).
136. Anderson JW, Johnstone BM and Cook-Newell ME, Meta-analysis of the effects of soy protein intake on serum lipids. New Engl J Med 333:276-282 (1995).
137. Nestel PJ, Yamashita T and Sasahara T, Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and premenopausal women. Arterioscler, Thromb Vas Biol 17:3392-3398 (1997).
138. Hodgson JM, Puddey IB, Bedin LJ, Mom TA and Croft KD, Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentration: a randomised controlled trial in humans. J Nutr 128:728-732 (1998).
139. Sirtori CR, Even R and Lovati MR, Soyabean diet and plasma cholesterol: from therapy to molecular mechanisms. Ann N Y Acad Sci 676:188-201 (1993).
140. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M and Arichi S, Effects of stilbene components of the roots of Polygonum cuspidatum Sieb, et Zucc. on lipid metabolism. Chem Pharmacent Bull 30:1766-1770 (1982).
141. Goldberg DM, Tsang E, Karumanchiri A and Soleas GJ, Direct injection gas chromatographic mass spectrometric assay for trans-resveratrol. A J Enol Vitic 49:142-151 (1998).
142. Wilson T, Knight TJ, Beitz DC, Lewis DS and Engen RL, Resveratrol promotes atherosclerosis in hypercholesterolemic rats. Life Sci 59:15-21 (1996).
143. Turrens JF, Lariccia J and Gopal Nair M, Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats. Free Radic Res Commun 27:557-562 (1997).
144. Bertelli AAE, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M and Bertelli A, Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 17:1-3 (1995).
145. Pace-Asciak CR, Hahn SE, Diamandis EP, Soleas G and Goldberg DM, The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235:207-219 (1995).
146. Jayatilake GS, Jayasuriya H, Lee ES, Koonchanok NM, Geahlen RL, Ashendel CL, McLaughlin JL and Chang CJ, Kinase inhibitors from Polygonum cuspidatum. J Nat Prod 56:1805-1810 (1993).
147. Bertelli AAE, Giovannini L, de Caterina R, Bernini W, Migliori M, Fregoni M, Bavaresco L and Bertelli A, Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res 22:61-63 (1996).
148. Verache-Lembège M, Waffo P, Decendit A, Devaux G and Deffieux G, Polyhydroxystilbenes from Vitis vinifera L cells inhibitory effect on human platelet aggregation and molecular modeling. Presented at 18th Int Conf on Polyphenols, July (1996).
149. Orsini F, Pelizzoni F, Verotta L and Aburjai T, Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-D-glucopyranoside and related compounds. J Nat Prod 60:1082-1087 (1997).
150. Shan C, Yang S, He H, Shao S and Zhang P, Influence of 3,4,5-trihydroxystilbene-3-β-mono-D-glucoside on rabbit platelet aggregation and thromboxane B2 production in vitro. Zhongguo Yaoli Xuebao 11:527-530 (1990).
151. Kimura Y, Okuda H and Arichi S, Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 83:275-278 (1985).
152. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewiczsapuntzakis M, Guo P and Kukreja SC, Dietary soybean protein prevents bone loss in an ovarectomised rat model of osteoporosis. J Nutr 126:161-167 (1996).
153. Potter SM, Bakhit RM, Essex-Sorlie DL, Weingartner KE, Chapman KL, Nelson RA, Pradhudesai M, Savage WD, Nelson AI, Winter LW and Erdman Jr JW, Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am J Clin Nutr 58:501-506 (1993).
154. Honore EK, Williams JK, Anthony MS and Clarkson TB, Soy isoflavones enhance vascular reactivity in atherosclerotic female macaques. Fertil Steril 67:148-154 (1997).
155. Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD and West L, Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 84:895-898 (1999).
156. Chen CK and Pace-Asciack CR, Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 27:363-366 (1996).
157. Fitzpatrick DF, Hirschfield SL and Coffey RG, Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265:H774-H778 (1993).
158. Morton MS, Chan PSF, Cheung C, Blacklock N, MatosFerreira A, AbranchesMonteiro L, Correia R, Lloyd S and Griffiths K, Lignins and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong and the UK. Prostate 32:122-128 (1997).